INTERNATIONAL PATENT: TONGHUA DONGBAO PHARMACEUTICAL CO., LTD., 通化东宝药业股份有限公司 FILES APPLICATION FOR "USE OF COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF IN TREATMENT OF GLUCOSE METABOLIC DISEASES"

GENEVA, May 10 -- TONGHUA DONGBAO PHARMACEUTICAL CO., LTD. (Dongbao New VillageTonghua, Jilin 134123), 通化东宝药业股份有限公司 (中国吉林省通化市东宝新村) filed a patent application (PCT/CN2025/131645) for "USE OF COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF IN TREATMENT OF GLUCOSE METABOLIC DISEASES" on Oct 31, 2025. With publication no. WO/2026/092666, the details related to the patent application was published on May 07, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organ...